» Articles » PMID: 29689270

Mutual Suppression of MiR-125a and Lin28b in Human Hepatocellular Carcinoma Cells

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2018 Apr 25
PMID 29689270
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNA-125a exhibits an antiproliferative activity and is downregulated in several types of tumors, including hepatocellular carcinoma where it targets sirtuin-7, matrix metalloproteinase-11, and c-Raf. Another target of miR-125a is Lin28, a pluripotency factor that is generally undetectable in differentiated cells but is often upregulated/reactivated in tumors where it acts as an oncogenic factor promoting cell proliferation and tumor progression. In this study we show that downregulation of Lin28b by miR-125a partially accounts for its antiproliferative activity toward hepatocellular carcinoma cells. We also found that Lin28b is able to bind a conserved GGAG motif of pre-miR-125a and to inhibit its maturation in hepatocellular carcinoma cells. Reciprocal inhibition between miR-125a and Lin28b reasonably generates a positive feedback loop where reactivation of Lin-28b inhibits the expression of both miR-125a and let-7, reinforcing its own expression and leading to a marked overexpression of the mitogenic targets of the two miRNAs. On the other hand, perturbation of these circuits by overexpression of miR-125a suppresses Lin28b leading to a decreased cell proliferation. Overall, these data support a tumor suppressive role for miR-125a and contribute to the elucidation of its molecular targets.

Citing Articles

Transcriptomic-Based Identification of miR-125a Novel Targets in Human Hepatocarcinoma Cells.

De Leo I, Mosca N, Pezzullo M, Valletta D, Manfrevola F, Mele V Biomolecules. 2025; 15(1).

PMID: 39858538 PMC: 11763984. DOI: 10.3390/biom15010144.


A Transcriptomic Biomarker for Predicting the Response to TACE Correlates with the Tumor Microenvironment and Radiomics Features in Hepatocellular Carcinoma.

Wang C, Leng B, You R, Yu Z, Lu Y, Diao L J Hepatocell Carcinoma. 2024; 11:2321-2337.

PMID: 39619603 PMC: 11606151. DOI: 10.2147/JHC.S480540.


The role of LIN28B in tumor progression and metastasis in solid tumor entities.

Gewalt T, Noh K, Meder L Oncol Res. 2023; 31(2):101-115.

PMID: 37304235 PMC: 10208000. DOI: 10.32604/or.2023.028105.


miR-125b prevent the progression of esophageal squamous cell carcinoma through the p38-MAPK signaling pathway.

Cheng C, Mao Q, Shi M, Lu H, Shen B, Xiao T J Gastrointest Oncol. 2021; 11(6):1113-1122.

PMID: 33456986 PMC: 7807273. DOI: 10.21037/jgo-20-546.


Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma.

Wang M, Huang S, Chen Z, Han Z, Li K, Chen C BMC Cancer. 2020; 20(1):1136.

PMID: 33228611 PMC: 7684760. DOI: 10.1186/s12885-020-07625-3.